Neuronostics Ltd, developer of the revolutionary seizure susceptibility assessment technology called #BioEP, announces the appointment of Ross Parkman as Technical & Operations Director.  Mr Parkman, who previously 15 years at IT solutions provider, Nexus Open Systems Ltd, will lead the product development activity of the Company and will be responsible for the identification, development and delivery of the customer platform for #BioEP. 

Commenting on the recent hiring, company Managing Director, Ashley Cooper, said “We are delighted to welcome Ross to the management team. He brings a wealth of systems specification, design and installation expertise to the position which is everything we will need to deliver BioEP to the Neurologists and EEG Physiologists that will one day use our technology in a clinical setting”.

On his recent appointment Ross Parkman said, “I am very excited to be joining such an exciting young company at such a pivotal moment in its history, Neuronostics has a real sense of mission about its business, which is both inspiring and refreshing. The development of BioEP presents a significant technical challenge but I look forward to working with people with epilepsy, those with lived experience, special interest groups, researchers, doctors and neurologists to bring the benefits of #BioEP to the wider community”.